Hospice News
OCTOBER 6, 2023
Researchers reviewed electronic medical record data for nearly 2,000 adolescents and young adults who died between 2003 and 2019. When their last documented goals of care were evaluated, 69% of these patients chose care that focused on palliation, the study found.
Minority Nurse
FEBRUARY 1, 2024
To this day, the legacies of structural racism live on in health disparities that would have no place in 21st-century America if we had already learned our lessons and lived up to the potential outlined in our country’s founding documents. Nonetheless, disproportionately negative statistics don’t lie.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
DECEMBER 15, 2022
Deanna Heath: I have worked in the post-acute space since 2003 with a focus in hospice. KanTime can capture affiliated providers, documents and palliative care-to-hospice transitions seamlessly by overlaying medical records for easy reference. Hospice News: What career experiences do you most draw from, in your role today?
AlayaCare
FEBRUARY 6, 2020
Founded in 2003 by the owners of a home care agency, Arrow Solutions is distinguished by the desire and capability to create solutions that meet each home health agency’s client specific needs.
1-800-HOSPICE
MARCH 28, 2023
Among patients whose charts document a prognostic disclosure, nearly half of patients report not having a prognosis conversation. 2003; 51 (10): 1398-1403. 2003; 51 (10): 1398-1403. 2003; 51 (10): 1398-1403. 2003; 327: 745-748. 2 Patient recall of prognostic conversations can be poor. Fried T, Bradley E, O’Leary J.
Minority Nurse
MARCH 19, 2024
In 2003, she was one of the first nurses to practice from behind a camera as part of a teleICU. Numbers skyrocketed from 2.1 million in the year before the pandemic to 32.5 million from March 2020 to February 2021. Teresa Rincon, PhD, RN, FCCM, is a pioneer in virtual nursing.
Healthcare Law Insights blog
JUNE 30, 2023
Food and Drug Administration (FDA) published a draft guidance document with foundational considerations for researchers that are developing psychedelic drugs for the treatment of medical conditions. The document frequently refers readers to existing guidance while noting key considerations that are unique to psychedelic drugs in each section.
Expert insights. Personalized for you.
270 
Let's personalize your content